NanoViricides, Inc. NNVC
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -10.98% | -16.53% | -5.38% | -3.66% | 31.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.40% | -17.15% | -11.88% | -14.83% | 12.63% |
| Operating Income | 13.40% | 17.15% | 11.88% | 14.83% | -12.63% |
| Income Before Tax | 13.19% | 16.82% | 11.17% | 14.04% | -14.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.19% | 16.82% | 11.17% | 14.04% | -14.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.19% | 16.82% | 11.17% | 14.04% | -14.14% |
| EBIT | 13.40% | 17.15% | 11.88% | 14.83% | -12.63% |
| EBITDA | 12.06% | 16.22% | 11.17% | 15.16% | -14.06% |
| EPS Basic | 35.67% | 37.24% | 32.47% | 32.53% | 9.04% |
| Normalized Basic EPS | 35.74% | 37.27% | 32.46% | 32.49% | 8.99% |
| EPS Diluted | 35.67% | 37.24% | 32.47% | 32.53% | 9.04% |
| Normalized Diluted EPS | 35.74% | 37.27% | 32.46% | 32.49% | 8.99% |
| Average Basic Shares Outstanding | 33.56% | 32.12% | 32.18% | 29.06% | 27.40% |
| Average Diluted Shares Outstanding | 33.56% | 32.12% | 32.18% | 29.06% | 27.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |